Invo Bioscience Inc Reports Results For The Quarter Ended In December: Earnings Summary

INVO Fertility

17/04/2023 22:01

* INVO Bioscience Inc  INVO.OQ  reported a quarterly
adjusted loss
of 23 cents​​ per share for the quarter ended in December. The
lone analyst forecast for the quarter was for a loss of 19 cents
per share.
    * Revenue fell 90.9% to $278.00 thousand from a year ago;
analysts
expected $257.00 thousand. 
    * INVO Bioscience Inc's reported EPS for the quarter was a
loss
of 23 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * INVO Bioscience Inc shares had fallen by 26.3% this
quarter and
gained 11.1% so far this year.
    * The company reported a quarterly loss of $2.77 million.
    * Wall Street's median 12-month price target for INVO
Bioscience
Inc is $2.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
April 17 at 09:01 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.19          -0.23          Missed
 Sep. 30 2022      -0.13          -0.21          Missed
 Jun. 30 2022      -0.24          -0.23          Beat
 Mar. 31 2022      -0.25          -0.22          Beat